The Central Drugs Standard Control Organization vide notice dated 21 September 2020 has issued guidelines in consideration with WHO, USFDA and EMA guidelines for development of Covid-19 vaccinations. The guidelines are not binding and does not override any existing statutory requirements, but is recommendatory in nature. Any objections or comments shall be forwarded to dci@nic.in within 12 October 2020.
Bharat Cleantech Manufacturing Platform to spur innovation, help India become global leader in sustainability
The launch of the Bharat Cleantech Manufacturing Platform will provide an opportunity for the Indian firms to collaborate, to co-innovate and will help provide a